Bridgeway Capital Management’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $23K | Sell |
|
|||||
|
2024
Q1 | $506K | Sell |
|
|||||
|
2023
Q4 | $465K | Buy |
|
|||||
|
2023
Q3 | $258K | Buy |
|
|||||
|
2023
Q2 | $236K | Buy |
|
|||||
|
2023
Q1 | $139K | Buy |
|
|||||
|
2022
Q4 | $244K | Sell |
|
|||||
|
2022
Q3 | $86K | Hold |
|
|||||
|
2022
Q2 | $93K | Hold |
|
|||||
|
2022
Q1 | $177K | Hold |
|
|||||
|
2021
Q4 | $224K | Sell |
|
|||||
|
2021
Q3 | $369K | Sell |
|
|||||
|
2021
Q2 | $500K | Buy |
|
|||||
|
2021
Q1 | $514K | Sell |
|
|||||
|
2020
Q4 | $772K | Sell |
|
|||||
|
2020
Q3 | $642K | Sell |
|
|||||
|
2020
Q2 | $1.47M | Buy |
|
|||||
|
2020
Q1 | $582K | Buy |
|
|||||
|
2019
Q4 | $513K | Sell |
|
|||||
|
2019
Q3 | $713K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $325K | Sell |
|
|||||
|
2017
Q4 | $617K | Sell |
|
|||||
|
2017
Q3 | $934K | Hold |
|
|||||
|
2017
Q2 | $745K | Hold |
|
|||||
|
2017
Q1 | $363K | Sell |
|
|||||
|
2016
Q4 | $499K | Sell |
|
|||||
|
2016
Q3 | $785K | Hold |
|
|||||
|
2016
Q2 | $798K | Hold |
|
|||||
|
2016
Q1 | $654K | Hold |
|
|||||
|
2015
Q4 | $628K | Buy |
|
|||||
|
2015
Q3 | $393K | Buy |
|
|||||
|
2015
Q2 | $479K | Buy |
|
|||||
|
2015
Q1 | $315K | Buy |
|
|||||
|
2014
Q4 | $213K | Buy |
|
|||||
|
2014
Q3 | $160K | Buy |
|